“TED is 5 times more prevalent in women, and because of that, men are often overlooked for the diagnosis,” Nijm said. The ...

Following closing, combined company plans to progress Yarrow's lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor ("TSHR") antibody for Graves' disease ("GD") ...

Investing.com -- Vyne Therapeutics Inc (NASDAQ:VYNE) stock surged 77.9% in premarket trading Wednesday after announcing a definitive merger agreement with Yarrow Bioscience, a clinical-stage ...

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

Your hair is more than just style. It reveals your inner health. Changes like thinning or colour loss signal internal ...

Air pollution might play a role in people's risk for developing autoimmune diseases like lupus and rheumatoid arthritis, a ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...

High-intensity interval training outperforms standard home exercise in improving fitness for patients with inflammatory ...

The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from Viridian Therapeutics.

The past decade has seen a major shift in how thyroid cancer is diagnosed and managed. R. Michael Tuttle, MD, chief of ...

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...